University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 4P-16-2


Immune Activation and Cellular Response from Enzalutamide Alone or with Radium223 in Men with Metastatic, Castration-Resistant Prostate Cancer

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Other
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  David Quinn, M.D.
Other Trial Staff:  Cheryl Kefauver, Coordinator, Lagrimas Ilagan, D.M., Honorina Enright, D.M., Charis Barg, Coordinator, Bartolo Santos, Coordinator, Peter Alexander, Coordinator, Jennifer Donaldson, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.